Riboflavin 1975
DOI: 10.1007/978-1-4613-4419-3_12
|View full text |Cite
|
Sign up to set email alerts
|

Hormonal Regulation of Riboflavin Metabolism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
4
1

Year Published

1980
1980
2006
2006

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 69 publications
2
4
1
Order By: Relevance
“…For example, riboflavin plasma riboflavin concentrations may decrease in pregnancy [15] and in response to treatment with antimalarial drugs [1]. Moreover, evidence has been provided that hypothyroidism impairs the conversion of riboflavin to its coenzyme forms [30,31].…”
Section: Discussionsupporting
confidence: 41%
“…For example, riboflavin plasma riboflavin concentrations may decrease in pregnancy [15] and in response to treatment with antimalarial drugs [1]. Moreover, evidence has been provided that hypothyroidism impairs the conversion of riboflavin to its coenzyme forms [30,31].…”
Section: Discussionsupporting
confidence: 41%
“…Thyroid hormones also change the FAD content in liver; this may be due to regulation of flavokinase activity (214). The increase in flavokinase activity induced by thyroxine is not blocked by actinomycin D (214,217). This fi nding, plus the observation that an unidentifi ed small molecule (possibly riboflavin) in liver extracts from hyperthyroid animals apparently stabilizes the enzyme, suggests that thy roxin increases activity by modifying fl avokinase degradation.…”
Section: Conversion To Coenzymatic Formssupporting
confidence: 40%
“…Co-administra tion of aldosterone and riboflavin analogues [7,8-dimethyl-1O-formylmethyl isoalloxazine or 7,S-dimethyl-1O-(2'-hydroxyethyl) isoalloxazine] decreased the formation of renal FMN while increasing the urinary output of Na+, compared to aldosterone alone (253); hence, it was concluded that stimula tion of FMN (and FAD) synthesis by aldosterone may be a causative factor in the increased reabsorption of Na+. Thyroid hormones also change the FAD content in liver; this may be due to regulation of flavokinase activity (214). The increase in flavokinase activity induced by thyroxine is not blocked by actinomycin D (214,217).…”
Section: Conversion To Coenzymatic Formscontrasting
confidence: 40%
See 1 more Smart Citation
“…These and a number of more recent investigations suggest that the enhancement of carcinogenesis by azo dyes in riboflavin deficient animals is likely due to the fact that flavin containing enzymes are involved in demethylation of these drugs and in cleavage of their azo linkage. In riboflavin deficiency, the hepatic concentration of FAD is reduced to one-third of normal [17], and it is likely that under these conditions there is diminished degradation of azo dyes by azo reductase. In the special case of azo compounds attached to benzidine, azo reduction leads to a more potent mutagenic compound, rather than to an inactivated one [18].…”
Section: Riboflavinmentioning
confidence: 44%